RY 174.21 0.4845% TD 77.21 -0.3099% SHOP 113.1 0.5155% CNR 157.51 -1.1299% ENB 57.59 0.1565% CP 112.08 -0.5678% BMO 129.49 0.3332% TRI 232.87 0.7921% CNQ 49.045 1.1654% BN 76.23 1.3023% ATD 73.74 -0.6066% CSU 4426.6099 0.3812% BNS 73.69 -0.1896% CM 86.29 0.4657% SU 53.56 0.7714% TRP 65.64 0.845% NGT 78.23 1.1246% WCN 250.66 0.2239% MFC 42.08 -0.1898% BCE 46.14 0.2172%
Last update at 2024-10-17T18:53:00Z
Is It Too Late To Consider Buying LifeStance Health Group, Inc. (NASDAQ:LFST)?
Fri 20 Sep 24, 10:37 AMLifeStance Health Group, Inc. (LFST): The Best Among Morgan Stanley’s Highest Conviction Stocks
Tue 27 Aug 24, 08:45 PMWall Street Analysts Believe LifeStance Health (LFST) Could Rally 39.38%: Here's is How to Trade
Wed 14 Aug 24, 01:55 PMLifeStance Health Group Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
Sat 10 Aug 24, 01:13 PMLifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates
Thu 08 Aug 24, 11:35 AMLifeStance Reports Second Quarter 2024 Results
Thu 08 Aug 24, 10:00 AM7 Low-Cost Stocks With Unexpected Growth Potential
Fri 02 Aug 24, 11:05 AMLifeStance Health Group (LFST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Thu 01 Aug 24, 02:01 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -232.73000M | -333.10500M | - | 7.88M |
| Minority interest | - | - | - | - |
| Net income | -215.56400M | -307.19700M | - | 5.67M |
| Selling general administrative | 377.99M | 433.73M | - | 41.06M |
| Selling and marketing expenses | - | - | - | - |
| Gross profit | 237.02M | 201.51M | - | 62.40M |
| Reconciled depreciation | 69.20M | 54.14M | - | 6.09M |
| Ebit | -210.17400M | -286.35300M | 15.44M | 15.24M |
| Ebitda | -141.19400M | -233.68600M | - | 21.34M |
| Depreciation and amortization | 68.98M | 52.67M | - | 6.09M |
| Non operating income net other | -2.62800M | -7.84100M | - | - |
| Operating income | -210.17400M | -286.35300M | - | 15.24M |
| Other operating expenses | 1069.72M | 953.86M | 16.83M | 197.28M |
| Interest expense | 19.93M | 38.91M | 0.00000M | 5.41M |
| Tax provision | -17.16600M | -25.90800M | - | 2.21M |
| Interest income | - | - | - | - |
| Net interest income | -19.92800M | -38.91100M | - | -5.40900M |
| Extraordinary items | - | - | - | - |
| Non recurring | - | - | - | - |
| Other items | - | - | - | - |
| Income tax expense | -17.16600M | -25.90800M | -6.34100M | 2.21M |
| Total revenue | 859.54M | 667.51M | - | 212.52M |
| Total operating expenses | 447.19M | 487.86M | - | 47.16M |
| Cost of revenue | 622.52M | 466.00M | - | 150.12M |
| Total other income expense net | -22.55600M | -46.75200M | - | -7.36600M |
| Discontinued operations | - | - | - | - |
| Net income from continuing ops | -215.56400M | -307.19700M | - | 5.67M |
| Net income applicable to common shares | -215.56400M | -343.94700M | -286.36900M | -58.90400M |
| Preferred stock and other adjustments | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 2233.21M | 2173.87M | 1927.11M | 1569.73M | 280.78M |
| Intangible assets | 221.07M | 263.29M | 300.36M | 332.80M | 14.95M |
| Earning assets | - | - | - | - | - |
| Other current assets | 21.27M | 23.73M | 4.34M | 10.52M | 4.81M |
| Total liab | 804.28M | 655.15M | 382.08M | 571.89M | 447.13M |
| Total stockholder equity | 1428.93M | 1518.72M | 1545.03M | 997.84M | -166.35500M |
| Deferred long term liab | - | 38.70M | 54.28M | - | - |
| Other current liab | 146.42M | 124.89M | 16.09M | 62.50M | 46.71M |
| Common stock | 3.79M | 3.76M | 3.74M | 1009.51M | 0.00300M |
| Capital stock | 3.79M | 3.76M | 3.74M | 1009.51M | 0.00300M |
| Retained earnings | -760.84600M | -572.63600M | -357.07200M | -13.12500M | -166.35800M |
| Other liab | - | 41.48M | 107.91M | 98.44M | 9.90M |
| Good will | 1293.35M | 1272.94M | 1204.54M | 1098.66M | 214.61M |
| Other assets | - | 6.37M | 3.45M | 2.65M | 1.36M |
| Cash | 78.82M | 108.62M | 148.03M | 18.83M | 3.48M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 202.87M | 176.00M | 116.75M | 75.92M | 55.01M |
| Current deferred revenue | - | - | 85.19M | - | - |
| Net debt | 432.22M | 367.87M | 9.39M | 343.70M | 75.83M |
| Short term debt | 49.40M | 38.82M | 1.32M | - | - |
| Short long term debt | - | 2.35M | 1.32M | - | - |
| Short long term debt total | 511.04M | 476.49M | 157.42M | 362.53M | 79.31M |
| Other stockholder equity | 2183.68M | 2084.32M | 1898.36M | 1.45M | - |
| Property plant equipment | - | 194.19M | 152.24M | 59.35M | 22.43M |
| Total current assets | 225.73M | 233.22M | 266.52M | 76.28M | 27.43M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | -17.51000M | 40.13M | -433.61900M | -395.92000M |
| Short term investments | - | - | - | - | - |
| Net receivables | 125.64M | 100.87M | 76.08M | 46.93M | 19.13M |
| Long term debt | 280.29M | 225.08M | 157.42M | 362.53M | 79.31M |
| Inventory | 0.00000M | - | 38.07M | - | - |
| Accounts payable | 7.05M | 12.29M | 14.15M | 13.42M | 8.30M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 2.30M | 3.27M | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 3.76M | 3.74M | 1009.51M | 0.00300M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | -572.63600M | -357.07200M | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 7.96M | 10.79M | 3.45M | 2.65M | 1.36M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2007.48M | 1940.65M | 1660.59M | 1493.45M | 253.35M |
| Capital lease obligations | 227.83M | 251.41M | - | - | - |
| Long term debt total | - | 225.08M | 157.42M | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -139.46100M | -194.07600M | - | -73.37500M |
| Change to liabilities | 21.32M | 0.62M | 0.83M | 2.54M |
| Total cashflows from investing activities | -139.46100M | -194.07600M | -861.16900M | -73.37500M |
| Net borrowings | 60.68M | -212.59000M | 291.41M | 55.45M |
| Total cash from financing activities | 47.26M | 313.86M | 912.27M | 48.46M |
| Change to operating activities | -2.94200M | 25.73M | 11.72M | 6.22M |
| Net income | -215.56400M | -307.19700M | -38.07000M | 5.67M |
| Change in cash | -39.40800M | 129.20M | 42.57M | -7.86400M |
| Begin period cash flow | 148.03M | 18.83M | 3.48M | 11.35M |
| End period cash flow | 108.62M | 148.03M | 3.48M | 3.48M |
| Total cash from operating activities | 52.79M | 9.42M | -8.53300M | 17.05M |
| Issuance of capital stock | 0.00000M | 549.90M | - | 0.00000M |
| Depreciation | 69.20M | 54.14M | 31.05M | 6.09M |
| Other cashflows from investing activities | -60.20600M | -99.58400M | - | - |
| Dividends paid | - | - | - | - |
| Change to inventory | - | - | - | - |
| Change to account receivables | -21.66300M | -24.21300M | -13.30500M | -5.75900M |
| Sale purchase of stock | 0.00000M | 549.90M | - | 0.00000M |
| Other cashflows from financing activities | 235.03M | 75.34M | -32.71800M | 48.95M |
| Change to netincome | 191.03M | 258.54M | -1.72900M | 1.58M |
| Capital expenditures | 79.25M | 94.49M | 38.07M | 14.31M |
| Change receivables | -21.66300M | -24.21300M | - | - |
| Cash flows other operating | 6.52M | -44.45600M | - | - |
| Exchange rate changes | - | - | - | - |
| Cash and cash equivalents changes | -39.40800M | 129.20M | - | - |
| Change in working capital | -16.93800M | 2.14M | - | 2.99M |
| Stock based compensation | 187.43M | 259.44M | - | 0.05M |
| Other non cash items | 45.40M | 27.85M | - | 0.48M |
| Free cash flow | -26.46600M | -85.07200M | - | 2.73M |
Sector: Healthcare Industry: Medical Care Facilities
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| LFST Lifestance Health Group Inc |
-0.095 1.30% | 7.21 | - | 151.52 | 2.18 | 1.61 | 2.59 | -26.0418 |
| HCA HCA Holdings Inc |
-4.57 1.12% | 404.66 | 13.19 | 13.66 | 1.13 | 293.44 | 1.77 | 8.22 |
| FSNUY Fresenius SE & Co KGaA ADR |
-0.16 1.74% | 9.03 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| FSNUF Fresenius SE & Co. KGaA |
- -% | 37.50 | 16.76 | 9.62 | 0.42 | 0.79 | 0.78 | 5.31 |
| JDHIY JD Health International Inc |
- -% | 3.20 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
4800 North Scottsdale Road, Scottsdale, AZ, United States, 85251
| Name | Title | Year Born |
|---|---|---|
| Mr. Kenneth Alan Burdick | CEO & Chairman | 1959 |
| Mr. Danish J. Qureshi | Pres & COO | 1984 |
| Mr. David Patrick Bourdon | Chief Financial Officer & Treasurer | 1969 |
| Mr. Warren Gouk | Chief Admin. Officer | NA |
| Ms. Monica Prokocki | VP of Investor Relations | NA |
| Mr. Ryan Pardo | Chief Legal Officer & Sec. | 1976 |
| Brooke Matthews | Director of PR | NA |
| Ms. Felicia Gorcyca | Chief People Officer | 1979 |
| Mr. Pablo Pantaleoni | Chief Digital Officer | 1988 |
| Mr. Kevin Michael Mullins | Chief Devel. Officer | 1985 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...